| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |